Seroclearance of Hbsag in Chronic Hepatitis B Virus Patients on Lamivudine Therapy: A 10 Year Experience

INTRODUCTION: The aim of this study was to determine hepatitis B surface antigen (HBsAg) seroclearance rate among patients treated with lamivudine at a specialized tertiary care referral hospital in Tehran, Iran. METHODS: All patients on lamivudine (biovudin®) therapy at a dose of 100 mg/day, who sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sali, Shahnaz, Merza, Muayad A., Saadat, Sina, Mustafa, Nazik H., Queiky, Farzam, Yadegarynia, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Center of Science and Education 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803854/
https://www.ncbi.nlm.nih.gov/pubmed/26153167
http://dx.doi.org/10.5539/gjhs.v7n6p101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803854/
https://www.ncbi.nlm.nih.gov/pubmed/26153167
http://dx.doi.org/10.5539/gjhs.v7n6p101

Ejemplares similares